To further promote the development of cervical disease diagnosis and treatment technology and improve the professional level of primary doctors in cervical cancer screening, colposcopy and precancerous lesions treatment, the China Medical Education Association held the "Hubei Cervical Disease New Progress Training Class and Standardized Colp your Phase) and Tongji Hospital associated with Huazhong University of Science and Technology Tongji Medical College from May 9 to 10, 2025 Meeting, well -known domestic experts conducted deep discussions on the HPV”。 Li Wei教授始于HPV感染与宫颈疾病之间的相关性，并过度检查了HPV治疗所面临的当前的伪造和挑战。他教导说，传统的治疗方法有一些局限性，并系统地解释了Ruilin抗HPV感染的崩溃。 E6/E7 GEN病毒表达的目标阻塞达到了“病毒清除作用 + VAG的双重机制”Inal微环境'。 Li教授将大量的临床研究数据和实际病例结合在一起，以详细说明Reinda抗抗性对临床应用的显着有效性，其安全性很高，为患者提供了新的治疗选择。李教授也强调。Bosen制药组可以共同调整粘膜屏障，增强局部免疫力，并进一步将HPV效应与Yin。宫颈疾病诊断和治疗领域相结合，从而为女性带来更多健康益处。